| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |